ARTICLE | Company News
Ferring, Intralytix deal
January 13, 2017 7:55 PM UTC
Ferring and Intralytix partnered to develop and commercialize bacteriophage therapies targeting microbiome dysbiosis of the female reproductive tract, oral cavity and skin. The partners entered a sepa...